Synapse: Your Connection to our MSK Authors
Meet: Richard M Steingart
Research Focus: Medicine; NE Emeritus

Cardiac safety of reduced cardiotoxicity surveillance during HER2-targeted therapy
synapse.mskcc.org/synapse/work...

#HER2Positive #BreastCancerResearch #Cardiotoxicity #CardioOncology

Navigating HER2+ breast cancer? Experts break down how to choose the right patients and sequence treatments for HER2+ metastatic disease. Get the latest insights. #BreastCancer #HER2Positive #Oncology #TCSC

www.cancernetwork.com/view/current...

🚨 Late-breaking from #ASCO25: Dr. Kohei Shitara presents LBA4002 – DESTINY-Gastric04! T-DXd challenges RAM+PTX in 2L HER2+ metastatic #gastriccancer & GEJA 🔬 Will this redefine the standard of care? ow.ly/bpNQ50W2SFk

#HER2Positive #ASCO2025

Real-world data show that #Tucatinib + trastuzumab + capecitabine offers clinical benefit in heavily pretreated HER2+ metastatic #BreastCancer, even after T-DXd. Observations support the use of tucatinib-based therapy in later treatment lines.
#HER2Positive #Oncology #RealWorldEvidence

Navigating treatment sequencing in HER2+ metastatic breast cancer is critical; especially when brain mets are involved. Second-line decisions change everything. Stay evidence-based. #TCSC #BreastCancer #HER2Positive #Oncology #CancerCare #BrainMetastase

www.onclive.com/view/managin...

Any advice on continuing to use a #coldcap despite losing clumps of hair please? #breastcancer #Her2positive #grade3 #hairloss

Not commonly seen without a clinical mass!
#PagetsDisease of nipple with associated invasion. Also #HGDCIS in subareolar ducts. Usually #ERNegative & #Her2Positive.
#pathsky
#Pathology
#BreastPath
😉

Treatment Algorithm series: discussion on HER2+ #BreastCancer

✅ APT data/TCHP
✅ Metastatic disease
✅ Her2/ER/PR+

Full discussion:
⭐️ oncbrothers.com/her2positive...
⭐️ www.cancernetwork.com/treatment-al...
⭐️ “Oncology Brothers” podcast

#bcsm #CancerSky #OncSky

@drsarahsammons.bsky.social

The Japanese phase III PRECIOUS study reveals that pertuzumab retreatment in combination with trastuzumab & chemotherapy significantly improves overall survival in patients with HER2-positive, locally advanced/metastatic breast cancer. #HER2Positive ascopost.com/news/februar...

EA1211/DIRECT aims to help doctors make better (more personalized) decisions around treatment for #patients with #HER2positive #BreastCancer. Consider learning more about this phase 2 #clinicaltrial if you have HER2-positive breast cancer. For more info: bit.ly/EA1211

Fighting HER2-positive breast cancer: Dr. Elena Shagisultanova is breaking new ground with a triple-block approach to outsmart this resilient cancer. Cutting-edge research is paving the way for better treatments. 🌟 #HER2Positive #BreastCancerResearch #MedSky
https://buff.ly/3CQbL8n.

Understanding HER2 in Breast Cancer:

Slamon et al.'s 1987 study on HER2/neu amplification paved the way for targeted therapies like Herceptin. #HER2Positive #BreastCancer

pubmed.ncbi.nlm.nih.gov/3798106/

🚨 Open Letter to Regence BlueCross BlueShield of Utah 🚨

I’m sharing this letter publicly to shed light on a critical issue affecting my wife, Raven, who is battling HER2-positive breast cancer.

#breastcancer #her2positive #HealthcareJustice #cancertreatment #InsuranceReform #standardsofcare

checking to make sure my boobs haven’t abandoned me just yet #breastcancer #her2positive